March 4, 2020

Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

• Xu et al discuss the potential clinical use of niclosamide, an FDA-approved anthelminthic, in treating COVID-19. 

Xu et al. (Mar 3, 2020). Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential. ACS Infect Dis. https://doi.org/10.1021/acsinfecdis.0c00052